Company profile
Dracen Pharmaceuticals company profile
Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients and potentially extend the benefits of immuno-oncology therapies. The company develops novel glutamine antagonists with direct anti-tumor apoptotoc properties as well as endogenous anti-tumor immune modulatory mechanisms which increases the number of responders to anti-cancer therapy and extend survival for anti-tumor responses in areas currently evading immuno-oncology approaches.
Business identity
- Website
- http://www.dracenpharma.com/
- Contact email
- [email protected]
- Phone number
- (917) 398-3710
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Rosedale, Indiana, United States
- Postal code
- 21202
- Country code
- US
- Continent
- North America